APA

Laperle A. H., Sances S., Yucer N., Dardov V. J., Garcia V. J., Ho R., Fulton A. N., Jones M. R., Roxas K. M., Avalos P., West D., Banuelos M. G., Shu Z., Murali R., Maidment N. T., Van Eyk J. E., Tagliati M. & Svendsen C. N. (20200421). iPSC modeling of young-onset Parkinson's disease reveals a molecular signature of disease and novel therapeutic candidates. : Nature medicine.

Chicago

Laperle A H, Sances S, Yucer N, Dardov V J, Garcia V J, Ho R, Fulton A N, Jones M R, Roxas K M, Avalos P, West D, Banuelos M G, Shu Z, Murali R, Maidment N T, Van Eyk J E, Tagliati M and Svendsen C N. 20200421. iPSC modeling of young-onset Parkinson's disease reveals a molecular signature of disease and novel therapeutic candidates. : Nature medicine.

Harvard

Laperle A. H., Sances S., Yucer N., Dardov V. J., Garcia V. J., Ho R., Fulton A. N., Jones M. R., Roxas K. M., Avalos P., West D., Banuelos M. G., Shu Z., Murali R., Maidment N. T., Van Eyk J. E., Tagliati M. and Svendsen C. N. (20200421). iPSC modeling of young-onset Parkinson's disease reveals a molecular signature of disease and novel therapeutic candidates. : Nature medicine.

MLA

Laperle A H, Sances S, Yucer N, Dardov V J, Garcia V J, Ho R, Fulton A N, Jones M R, Roxas K M, Avalos P, West D, Banuelos M G, Shu Z, Murali R, Maidment N T, Van Eyk J E, Tagliati M and Svendsen C N. iPSC modeling of young-onset Parkinson's disease reveals a molecular signature of disease and novel therapeutic candidates. : Nature medicine. 20200421.